A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer

Abstrakt

In this study- clinical phase II the efficacy and safety of the fully oral combination of oral vinorelbine (Navelbine oral) plus capacitabine (Xeloda) in metastatic breast cancer (MBC) patients pretreated with antracycline, was evaluated.

Klíčová slova

• phase II study
• oral vinorelbine
• capecitabine